Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide information on the risks and benefits of routine
blood pressure lowering (regardless of blood pressure level), and intensive lowering of blood
glucose levels, in patients with Type 2 diabetes at high risk of cardiovascular events. The
major outcomes of the study will be cardiovascular events (heart attack, stroke or dying as a
result of cardiovascular disease), as well as new or worsening diabetic eye and kidney
disease.
Phase:
Phase 3
Details
Lead Sponsor:
The George Institute
Collaborators:
Institut de Recherches Internationales Servier National Health and Medical Research Council, Australia University of Sydney
Treatments:
Gliclazide Indapamide Indapamide, perindopril drug combination Perindopril